Quince Therapeutics
QNCX
QNCX
101 hedge funds and large institutions have $241M invested in Quince Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 52
86% less capital invested
Capital invested by funds: $1.76B → $241M (-$1.52B)
Holders
101
Holding in Top 10
1
Calls
$20.6M
Puts
$15M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$7.09M | |
| 3 | +$6.62M | |
| 4 |
Two Sigma Advisers
New York
|
+$6.04M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.38M |
Top Sellers
| 1 | -$212M | |
| 2 | -$19.1M | |
| 3 | -$12.4M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$6.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.59M |